logo
What grade did North Ala. hospitals receive from the Leapfrog Hospital Safety report?

What grade did North Ala. hospitals receive from the Leapfrog Hospital Safety report?

Yahoo31-05-2025
NORTH ALABAMA (WHNT) — North Alabama hospitals received grades ranging from an A to two Fs.
The Leapfrog Group is an independent national nonprofit focused on patient safety. On May 1, the group released its grade reports for hospitals across the nation for Spring 2025.
The report card is like a school grade scale: A, B, C, D and F. These grades are 'assigned to all general hospitals in the United States based on their ability to protect patients from medical errors, accidents, injuries and infections,' the Leapfrog Group said.
Hospitals receive a score in multiple categories within the following sections: Infections, Problems with Surgery, Safety Problems, Practices to Prevent Errors and Doctors, Nurses & Hospital Staff. Each section can have up to seven different categories that can be given a performance score of Worse than Average, Average and Better than Average, which plays into the overall hospital grade.
Disclaimer: The Leapfrog Hospital Safety Grade scores hospitals on their overall performance in keeping patients safe from preventable harm and medical errors. The grades are derived from expert analysis of publicly available data using up to 31 evidence-based, national measures of hospital safety.
In the list, 13 North Alabama hospitals were graded, receiving a grade anywhere from A to F. But, which hospital received what grade? Find out in the list below!
Based on the data, Helen Keller Hospital is overall considered worse than average in the section titled 'Practices to Prevent Errors.' Specifically, handwashing, safe medication administration, and doctors' orders medications through the computer were in the red zone.
That being said, the 'Safety Problems' section, most of the reports from the data suggest the hospital is better than average. For this section, there were seven categories that the hospital was rated on. Five of the seven were labeled as better than average, while one was labeled as average and one was labeled as below average.
In previous years, Helen Keller Hospital received a relatively similar score, receiving a C for both Fall and Spring 2024, and a D for Fall 2023 and a C for Spring 2023.
Based on data collected from Leapfrog, the Shoals Hospital received a C for its Spring 2025 grade. While this seems bad, the data collected from Leapfrog isn't complete. Out of 32 categories to grade the hospital on, only 14 of the categories are given a performance level. Seven of those 14 rated categories scored better than average, showing up the most in the 'Practices to Prevent Errors' section.
The 18 other categories that were not given a performance level were labeled as 'not available.' Based on Leapfrog's website, ''Not Available' means that the hospital does not have data for this measure. This could be because the measure is related to a service the hospital does not provide. For example, a hospital that does not have an ICU would not be able to report data about ICUs. It could also be because the hospital had too few patients or cases to report data for a particular condition or procedure. A 'Not Available' result does not mean that the hospital withheld information from the public,' the group said.
The hospital, based on previous reports, has been all over the grade scale. In 2022, the hospital received an F for the Spring but a B for the Fall. In 2023, Shoals Hospital received a C for the Spring but a D for the Fall. For 2024, the hospital received a C for the entire year.
DeKalb Regional Medical Center was the ONLY North Alabama hospital to receive an A on its Spring 2025 report card. 14 of the categories were rated as better than average, with the best section being the 'Doctors, Nurses & Hospital Staff.'
A point of concern seemed to stem from the 'Problems with Surgery' section, where only one of the seven categories was rated as better than average. The rest were considered average, with one category labeled as worse than average. Still, the hospital received a 0.00 score for this section. The best hospital's score was graded as 0.00, with the worst being 0.327 and the average being 0.014.
In years past, DeKalb Regional Medical Center has been consistent in its scoring. In 2024, it received A's across the board for the year. In 2023, the hospital received a C for the Spring but an A for the Fall.
The Russellville Hospital received a C based on the data collected from Leapfrog, mainly due to the 'Practices to Prevent Errors' section. In this section, four of the six categories are labeled as worse than average, with communication about discharge labeled as average and the staff work together to prevent errors category blank because the hospital declined to report this information to the public.
The best section for the hospital could be considered as the 'Problems with Surgery' section, as four of the seven categories were given a performance score. Two of these categories received an average performance grade, while one received a better-than-average performance score and one received a worse-than-average performance score.
The Russellville Hospital, based on data from years past, seems to stay consistent with either a B or a C grade. In 2024, the hospital received a B for the Spring but a C for the Fall, similarly to 2023, where the Spring grade was a C but the Fall grade was a B.
Highlands Medical Center seemed to struggle in the 'Practices to Prevent Errors' section of the grading because four of the five categories given a performance score were considered worse than average. The hospital received a score of 15 for this section, simply because the Leapfrog data said the hospital declined to report its performance on this measure, so a score was assigned to reflect the lack of information available. The highest hospital score for this section was a 100, with the average hospital receiving an 80.23 score.
The hospital performed its best in the 'Problems with Surgery' category, receiving an average performance score from four of the five scored categories.
This grade is an improvement for the hospital, according to Leapfrog data. This is the first time the hospital has received a C since Spring 2022. After that, the hospital has continuously received a D on its report card until now.
The North Alabama Medical Center was one of two North Alabama hospitals that received this grade. For the sections that Leapfrog graded on, the 'Infections' section was given the best performance score. Six of the six categories in this section received a better-than-average performance score. The hospital received a 0.00 score, with the highest hospital's score being a 0.00. The average hospital's score was 0.719, and the hospital with the worst score in this section received a 2.850.
The section where this hospital could work on more is 'Safety Problems.' Seven categories were given a performance score. Two were scored as worse than average and four were given an average performance score.
In recent years, the hospital received a B for 2024, and Cs for both 2023 and 2022.
The area for improvement for the Athens-Limestone Hospital is 'Safety Problems.' Of the seven categories, four were given an average performance score and two were given a worse-than-average score. The hospital received an overall 1.00 score for this section. The hospital with the best score received a 0.53, the worst score was a 3.10 and the average hospital received a 1.00 score.
The Athens-Limestone Hospital scored the best in the 'Infections' section. Its overall score was 0.00, with the best score for a hospital being 0.00. The hospital with the worst score received a 2.850, and the average hospital score was 0.719.
For 2024, the hospital received a D for the Spring and a C for the Fall. For 2023 as a whole, it received a C.
Crestwood Medical Center, while receiving worse-than-average performance scores in the 'Doctors, Nurses & Hospital Staff' section, the hospital received better overall scores for the section. Five of the six categories in this section were in the red and one category was rated as average. However, the hospital's score was a 101.54 overall score, with the best hospital's score being 120.00. The hospital with the worst score received a 9.23 and the average hospital received a 117.49 score.
The hospital had the best overall performance score in the 'Problems with Surgery' section. Out of the seven categories, two were considered better than average, four were considered average and one was worse than average.
The grade of a C is a step up from the most recent grade for 2024, being a D for Fall and a C for Spring.
Huntsville Hospital was one of the two lowest-ranking hospitals in North Alabama. The hospital's worst-scoring section was 'Practices to Prevent Errors.' Its overall score was 15, according to Leapfrog. This is because the hospital reportedly declined to report its performance on this section, so Leapfrog assigned the hospital a score to reflect the lack of information available. Five of the six categories in this section were scored. Three of the five categories were scored worse than average while the other two were scored as average.
The hospital had the best section in 'Problems with Surgery.' While the performance scores appear to be low, the overall score provided by Leapfrog shows the hospital scored the same as the best hospital's score: 0.00. The average hospital score was 0.014 and the worst hospital scored 0.327.
This grade is one step down from 2024, with a grade of D. In both 2023 and 2022, Huntsville Hospital receied a C grade.
Madison Hospital was the other hospital in North Alabama to receive the lowest grade. The hospital received almost identical performance and overall scores to Huntsville Hospital. The hospital's worst-scoring section was 'Practices to Prevent Errors.' Its overall score was 15, according to Leapfrog. The average score for this section was 80.23, with the highest score being 100.
Madison Hospital's best-scoring section was also 'Problems with Surgery.' While the performance scores appear to be low, the overall score provided by Leapfrog shows the hospital scored the same as the best hospital's score: 0.00.
In 2024, the hospital also received a D for the year, which was a small step down from 2023. This year, the hospital received a C grade for the Spring and a D grade for the Fall.
Marshall Medical Center North was the only North Alabama hospital to receive a D grade. Based on available Leapfrog data, the hospital received the worst performance scores for the 'Infections' section. Its overall score was 2.452. The best score was 0.00, the worst was 2.850 and the average score was 0.719.
The hospital's best scoring section was 'Problems with Surgery.' Three of the seven sections are scored as better than average, two are average and two are scored as worse than average.
This grade is consistent with previous Leapfrog data. For 2024, the Marshall Medical Center North received a D for the Spring and a C for the Fall. However, for both 2023 and 2022, the hospital received a D grade.
The Decatur-Morgan Hospital-Decatur Campus had four of the five sections scoring in the nationwide best hospital's score: 'Infections,' 0.00; 'Problems with Surgery,' 0.00; 'Practices to Prevent Errors,' 100; 'Doctors, Nurses & Hospital Staff,' 120.
The worst section, scored for the hospital, was 'Safety Problems.' In this section, the hospital received an overall score of 1.17. The best hospital scored a 0.53, with the worst hospital scoring a 3.10.
This grade is consistent with previous years, considering 2024's yearly score was a B. In 2023, the hospital scored a C for the Spring, and the grade for the Fall was a B.
You can find out all the hospitals in Alabama or nationwide that were given a grade on the Leapfrog Hospital Safety Grade website here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US and China extend trade truce for another 90 days
US and China extend trade truce for another 90 days

Yahoo

time7 minutes ago

  • Yahoo

US and China extend trade truce for another 90 days

US President Donald Trump has extended a trade truce with China for another 90 days, delaying once again a dangerous showdown between the world's two biggest economies. Mr Trump posted on his Truth Social platform that he signed the executive order for the extension, and that 'all other elements of the Agreement will remain the same'. Beijing at the same time also announced the extension of the tariff pause, according to the Ministry of Commerce. The previous deadline was set to expire at 12.01am on Tuesday. Had that happened the US could have ratcheted up taxes on Chinese imports from an already high 30%, and Beijing could have responded by raising retaliatory levies on US exports to China. The pause buys time for the two countries to work out some of their differences, perhaps clearing the way for a summit later this year between Mr Trump and Chinese President Xi Jinping, and it has been welcomed by the US companies doing business with China. China said on Tuesday it would extend relief to American companies who were placed on an export control list and an unreliable entities list. After Mr Trump initially announced tariffs in April, China restricted exports of dual-use goods to some American companies, while banning others from trading or investing in China. The Ministry of Commerce said it would stop those restrictions for some companies, while giving others another 90-day extension. Reaching a pact with China remains unfinished business for Mr Trump, who has already upended the global trading system by slapping double-digit taxes – tariffs – on almost every country on earth. The EU, Japan and other trading partners agreed to lopsided trade deals with Mr Trump, accepting once unthinkably US high tariffs (15% on Japanese and EU imports, for instance) to ward off something worse. In June, the US and China reached an agreement to ease tensions. The US said it would pull back export restrictions on computer chip technology and ethane, a feedstock in petrochemical production, and China agreed to make it easier for US firms to get access to rare earths. 'The US has realised it does not have the upper hand,' said Claire Reade, senior counsel at Arnold & Porter and former assistant US trade representative for China affairs. In May, the US and China had averted an economic catastrophe by reducing massive tariffs they'd slapped on each other's products, which had reached as high as 145% against China and 125% against the US. Those triple-digit tariffs threatened to effectively end trade between the US and China and caused a frightening sell-off in financial markets. In a May meeting in Geneva, America's tariffs went back down to a still-high 30% and China's to 10%. Ms Reade does not expect much beyond limited agreements such as the Chinese saying they will buy more American soybeans and promising to do more to stop the flow of chemicals used to make fentanyl and to allow the continued flow of rare-earth magnets. But the tougher issues will likely linger, and 'the trade war will continue grinding ahead for years into the future', said Jeff Moon, a former US diplomat and trade official.

DLP Capital Named to Inc. 5000 List of Fastest Growing Companies for 13th Consecutive Year
DLP Capital Named to Inc. 5000 List of Fastest Growing Companies for 13th Consecutive Year

Yahoo

time7 minutes ago

  • Yahoo

DLP Capital Named to Inc. 5000 List of Fastest Growing Companies for 13th Consecutive Year

ST. AUGUSTINE, Fla. & BETHLEHEM, Pa., August 12, 2025--(BUSINESS WIRE)--DLP Capital, a private real estate investment firm headquartered in Florida and Pennsylvania, announced today that it has been named to the Inc. 5000 list of America's fastest-growing private companies for the 13th year in a row. The Inc. 5000, published once per year by the New York City-headquartered Inc. Magazine, is an annual ranking of the nation's fastest-growing companies as measured by cumulative revenue growth over the past three years. To be eligible for the 2025 Inc. 5000, companies must be "privately held, for profit, based in the U.S., and independent." In addition, contenders must have generated no less than $100,000 in revenue in 2021 and at least $2 million in revenue in 2024 to qualify. "To be on the Inc. 5000 for 13 years is a rare and remarkable feat," says Don Wenner, founder and CEO of DLP Capital. "It's an affirmation of the resounding demand for attainable workforce housing across the country, and a testament to the lasting dedication and trust that our investors, sponsors, residents, and employees have put in us." This year, DLP ranked #3,821 on the Inc. 5000, #344 in Florida, and #86 in the real estate category. "Disciplined thought, disciplined people, and disciplined action have led us to where we are today," says Wenner. "Looking ahead, we aim to multiply our impact on America's housing crisis by bringing Thriving Communities to life across our expanding portfolio of multifamily, build-to-rent, manufactured, and short-term vacation rental homes." DLP Capital joins an exclusive cohort of companies that have managed to grow despite inflationary headwinds, high interest rates, and mounting economic uncertainty. This year, the top 500 companies on the Inc. 5000 list achieved a median three-year revenue growth rate of 1,552% and collectively contributed over 48,000 jobs to the American economy during the same period. Inc. magazine will honor this year's awardees at the Inc. 5000 Conference & Gala, which will be held in Phoenix, Arizona from October 22–24, 2025. The Fall issue of Inc. magazine will feature the top 500 companies from the Inc. 5000 list. About DLP Capital: DLP Capital is a St. Augustine, FL and Bethlehem, PA-headquartered private real estate investment firm with over $5.25 billion in assets under management (AUM). Through its four sponsored funds, the firm invests, develops, finances, and operates attainable multifamily and single-family rental housing communities for America's working families. Founded in 2006 by Don Wenner in Pennsylvania's Lehigh Valley, DLP Capital is a thirteen-time Inc. 5000 honoree, most recently in 2025. View source version on Contacts Shannon Danford, Marketing Director(407) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Brain Stimulation Promising for Progressive Aphasia
Brain Stimulation Promising for Progressive Aphasia

Medscape

time8 minutes ago

  • Medscape

Brain Stimulation Promising for Progressive Aphasia

Transcranial magnetic stimulation (TMS) may augment standard language therapy to help slow the progression of primary progressive aphasia (PPA), a neurodegenerative disorder that erodes communication. In a randomized sham-controlled clinical trial, 6 months of active intermittent theta-burst TMS plus language therapy improved or mitigated decline in regional brain metabolism, trained language abilities, functional impairment, and neuropsychiatric symptoms in adults with PPA. The study was published online on August 11 in JAMA Network Open . Added Value? PPA is a heterogeneous clinical syndrome marked by progressive speech and/or language impairment. Most cases stem from frontotemporal degeneration or Alzheimer's disease. There are currently no effective drug treatments, although speech-language therapy has proven to be helpful. TMS can induce changes in cortical excitability, potentially promoting the reorganization of language networks, and has shown promise as adjunctive treatment for post-stroke aphasia. Previous studies examining the short-term effects of TMS on PPA reported 'encouraging' results, but the longer-term effects, beyond more than a few weeks of intervention, have not been examined, until now. For the study, the researchers led by Jordi Matias-Guiu, MD, PhD, with the Department of Neurology, Hospital Clínico San Carlos, Madrid, Spain, recruited 63 adults with early-stage PPA (42 women; mean age, 72 years). Participants were randomized (2:1) to either active intermittent theta-burst TMS or sham TMS for 6 months, immediately followed by evidence-based language therapy for PPA. The trial consisted of a 24-week treatment that included a 2-week intensive course, in which active TMS or sham TMS combined with language therapy was applied daily, followed by a maintenance phase in which the same stimulation was applied weekly for 22 weeks. Participants were assessed at baseline, 3 months after the start of the treatment, and at the end of the treatment (6 months following baseline). The main outcome was the standardized uptake value ratio (SUVR) on FDG PET imaging in the left hemisphere, assessed at baseline and at 6 months (immediately following the intervention). Feasible, Effective Option The primary outcome was positive with higher adjusted mean SUVR in the active group than in the sham TMS group (0.78 vs 0.77; P = .046). Active TMS was also associated with significant improvement on all secondary language outcomes at 6 months, including the mini linguistic state examination, with an adjusted mean difference at 6 months of 7.71 ( P = .002). Patients in the sham group worsened on this measure compared with those in the active group. Active TMS also led to improvement in confrontation naming of trained words, which improved by a mean 23.8 points in active recipients compared with sham TMS recipients. Functional independence also benefited, with daily-living scores falling (indicating better performance) by 5.4 points in the active group compared with the sham TMS group. Neuropsychiatric symptoms eased as well, with a 4-point advantage on the neuropsychiatric inventory scale. There were no significant differences in the number of adverse events. Adherence to treatment protocol was high (92%). 'Overall, these findings suggest that the combination of TMS and language therapy is a feasible and effective treatment option for PPA,' the researchers concluded. They said future studies should investigate the potential for TMS paired with an evidence-based speech-language intervention to sustain or extend these benefits beyond 6 months.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store